NON-SELECTIVE BETA-BLOCKERS AND MORTALITY IN CIRRHOSIS PATIENTS WITH OR WITHOUT REFRACTORY ASCITES: POST HOC ANALYSIS OF THREE LARGE RCT'S WITH 1198 PATIENTS

被引：1
|
作者：
Bossen, L. [1 ,2 ]
Krag, A. [3 ]
Vilstrup, H. [1 ]
Watson, H. [4 ]
Jepsen, P. [1 ,2 ]
机构：
[1] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark
[3] Odense Univ Hosp, Dept Med Gastroenterol, DK-5000 Odense, Denmark
[4] Sanofi, Sanofi Aventis R&D, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30087-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
O073
引用
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [1] DOES THE USE OF NON-SELECTIVE BETA-BLOCKERS IN CIRRHOSIS PATIENTS WITH ASCITES RESULT IN INCREASED MORTALITY?
    Mallawaarachchi, N.
    Sinha, R.
    Hayes, P.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S278 - S279
  • [2] Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites
    Onali, Simona
    Kalafateli, Maria
    Majumdar, Avik
    Westbrook, Rachel
    O'Beirne, James
    Leandro, Gioacchino
    Patch, David
    Tsochatzis, Emmanuel A.
    LIVER INTERNATIONAL, 2017, 37 (09) : 1334 - 1344
  • [3] Beta-Blockers in Patients with Cirrhosis and Refractory Ascites
    Albillos, Agustin
    Zamora, Javier
    HEPATOLOGY, 2011, 53 (05) : 1783 - 1783
  • [4] Beta-Blockers in Cirrhosis Patients With Refractory Ascites
    Robins, Anne
    Bowden, Anne
    Watson, William
    Smith, Fiona
    Gelson, William
    Griffiths, William
    HEPATOLOGY, 2014, 59 (05) : 2054 - 2055
  • [5] Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study
    Jensen, Morten Daniel
    Watson, Hugh
    Vilstrup, Hendrik
    Jepsen, Peter
    CLINICAL EPIDEMIOLOGY, 2023, 15 : 775 - 783
  • [6] Nonselective β-Blockers Do Not Affect Mortality in Cirrhosis Patients With Ascites: Post Hoc Analysis of Three Randomized Controlled Trials With 1198 Patients
    Bossen, Lars
    Krag, Aleksander
    Vilstrup, Hendrik
    Watson, Hugh
    Jepsen, Peter
    HEPATOLOGY, 2016, 63 (06) : 1968 - 1976
  • [7] IMPACT OF STATINS AND NON-SELECTIVE BETA-BLOCKERS IN HEPATIC ENCEPHALOPATHY AND ASCITES EVENTS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: A NATIONWIDE ANALYSIS
    Chumbe, Julton Tomanguillo
    Annie, Frank
    Ayoub, Mark
    Searls, Lauren
    Kemper, Suzanne
    Iqbal, Sara
    Anwar, Nadeem
    GASTROENTEROLOGY, 2023, 164 (06) : S1327 - S1327
  • [8] Effects of Beta-Blockers on Survival for Patients With Cirrhosis and Refractory Ascites
    Lo, Gin-Ho
    HEPATOLOGY, 2011, 53 (03) : 1068 - 1069
  • [9] Is This Really the End of Beta-Blockers in Patients with Cirrhosis and Refractory Ascites?
    Thevenot, Thierry
    Cervoni, Jean-Paul
    Monnet, Elisabeth
    Sheppard, Frances
    Di Martino, Vincent
    HEPATOLOGY, 2011, 53 (02) : 715 - 716
  • [10] Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial
    Dajti, Elton
    Villanueva, Candid
    Berzigotti, Annalisa
    Brujats, Anna
    Albillos, Agustin
    Genesca, Joan
    Garcia-Pagan, Juan C.
    Colecchia, Antonio
    Bosch, Jaume
    JOURNAL OF HEPATOLOGY, 2025, 82 (03)
12345